Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)

NCT04385368

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Long Beach, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site West Hollywood, California, United States
View all 140 locations
View Trial Details
Completed

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

NCT04529564

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • National Taiwan University Hospital-Hsinchu Branch Hsinchu, Taiwan
  • Chang Gung Medical Foundation-Kaohsiung Branch Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation-Keelung Branch Keelung, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Completed

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

NCT04194203

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital; Oncology Department Beijing, China
  • the First Hospital of Jilin University Changchun, China
View all 23 locations
View Trial Details
Completed

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

NCT04426825

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Hospital; Internal Medicine-Oncology Beijing, China
  • Beijing Chest Hospital; Oncology Department Beijing, China
  • West China Hospital, Sichuan University Chengdu, China
View Trial Details
Completed

Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)

NCT02414139

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations
  • Pacific Shores Medical Group SC Long Beach, California, United States
  • University Of California Los Angeles Dept of Onc Los Angeles, California, United States
  • University of California Irvine Medical Center Chao Family Chao Family Comp Cancer Center Orange, California, United States
  • H Lee Moffitt Cancer Center and Research Institute . Tampa, Florida, United States
View all 95 locations
View Trial Details
Completed

Durvalumab as Maintenance in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real World Data From an Expanded Access Program in Brazil

NCT04948411

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Núcleo de Oncologia da Bahia S.A Salvador, Estado de Bahia, Brazil
  • Instituto Mário Penna Belo Horizonte, Minas Gerais, Brazil
  • BP - A Beneficência Portuguesa de São Paulo São Paulo, Brazil
  • Sociedade Beneficente de Senhoras Hospital Sírio-Libanês São Paulo, Brazil
View Trial Details

Related conditions